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Abstract: Control of aedine mosquito vectors, either by mosquito population reduction or 
replacement with refractory mosquitoes, may play an essential role in the fight against arboviral 
diseases. In this review, we will focus on the development and application of biological 
approaches, both natural or engineered, to limit mosquito vector competence for arboviruses. 
The study of mosquito antiviral immunity has led to the identification of a number of host 
response mechanisms and proteins that are required to control arbovirus replication in 
mosquitoes, though more factors influencing vector competence are likely to be discovered. 
We will discuss key aspects of these pathways as targets either for selection of naturally 
resistant mosquito populations or for mosquito genetic manipulation. Moreover, we will 
consider the use of endosymbiotic bacteria such as Wolbachia, which in some cases have 
proven to be remarkably efficient in disrupting arbovirus transmission by mosquitoes, but 
also the use of naturally occurring insect-specific viruses that may interfere with arboviruses 
in mosquito vectors. Finally, we will discuss the use of paratransgenesis as well as 
entomopathogenic fungi, which are also proposed strategies to control vector competence. 
Keywords: arbovirus; Aedes; vector control; vector competence; antiviral defences; 
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1. Introduction 
Female anautogenous mosquitoes need a blood meal from a vertebrate host to reproduce. Therefore, 
they can act as vectors for numerous pathogens, e.g., arthropod-borne viruses (arboviruses) or parasites, 
responsible for both human and animal diseases. The most important mosquito-borne viruses include 
flaviviruses (Flaviviridae) such as dengue virus (DENV), yellow fever virus (YFV), West Nile virus 
(WNV); alphaviruses (Togaviridae) such as chikungunya virus (CHIKV), o’nyong-nyong virus 
(ONNV), Semliki Forest virus (SFV), Sindbis virus (SINV); and bunyaviruses (Bunyaviridae) such as 
Rift Valley fever virus (RVFV). All of these arboviruses are mainly transmitted by aedine species 
including Aedes aegypti and Ae. albopictus as well as Culex species, with the exception of ONNV which 
is the only known arbovirus to be transmitted by Anopheles, and more specifically the African malaria 
vector An. gambiae. In recent decades, the incidence of mosquito-borne viral infections has grown 
dramatically. For example, according to the World Health Organization (WHO), more than 2.5 billion 
people—over 40% of the world’s population—are estimated to be at risk from DENV alone. A recent 
study has evaluated the incidence of dengue infections to be around 390 million worldwide every year, 
of which 96 million manifest [1]. Moreover, mosquito-borne virus infections are continuously expanding 
their geographical range into new areas. The spread of infections from Africa and Asia to other 
continents is thought to be due to extensive travelling, trade, population growth in high-risk areas, 
globalization of vectors, urbanization, climatic change, as well as virus genome evolution [2–4]. The 
threat of a possible outbreak of dengue fever now exists in Europe. Local transmission of DENV by  
Ae. albopictus was reported for the first time in France and Croatia in 2010, and imported cases were 
detected in three other European countries. Moreover, an epidemic was reported in Madeira (Portugal) 
in 2012–2013 in which 2200 patients tested positive for DENV, 78 of whom were known to have 
travelled away from the island. This spread of DENV was aided by the establishment of Ae. aegypti in 
the region. Moreover, imported cases have been detected in a further 10 European countries in addition 
to mainland Portugal [5–8]. In 2005–2006, an outbreak of CHIKV, normally transmitted by Ae. aegypti, 
occurred in the Indian Ocean. This epidemic has been associated with a single nucleotide mutation in 
the viral E1 glycoprotein conferring more efficient dissemination and transmission by the secondary 
vector, Ae. albopictus, which is more prevalent in this region [9–11]. Given the worldwide distribution of 
Ae. albopictus, this CHIKV variant has spread into many countries [12]. Currently, there is a large 
CHIKV outbreak occurring in the Americas, which started in 2013 with the first reported cases of 
autochthonous transmission on this continent. According to the Pan America Health Organization 
(PAHO)/WHO, as of February 2015, local transmission has been identified in 50 countries or territories 
in the Caribbean, Central America, South America, and North America. From the beginning of the 
epidemic in 2013 up to February 2015, a total of 1,176,216 suspected and 27,136 laboratory-confirmed 
chikungunya cases have been reported from these areas. CHIKV will likely continue to spread to new areas 
in the Americas through the movement of infected people and mosquitoes to naïve regions [4,12,13]. 
There are currently no vaccines for a number of important human-infecting arboviruses including 
DENV and CHIKV. Therefore, the control of mosquito vectors is still the main tool to eradicate, or at 
least reduce, the incidence of arboviral diseases [14]. Insecticides, nets and the reduction of breeding 
sites are currently the main tools for mosquito vector control. However, growing insecticide resistance 
in mosquito vectors has increasingly limited the utility of chemical insecticides [15–18]. Moreover, 
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biting patterns of Ae. aegypti and Ae. albopictus, mainly during the day, makes the use of bed nets rather 
ineffective. On the other hand, larval habitats may be small, widely dispersed, and transient and it is 
difficult, if not impossible, to predict when and where the breeding sites will form, to find and treat them 
before the adults emerge. Thus, alternative methods of mosquito control are urgently needed. 
The efficiency of mosquito-borne disease transmission under natural conditions is referred to as the 
vectorial capacity, which is modelled by the following equation, first developed for modeling malaria 
transmission by Ross in 1910 and later refined by others [19]:  
? ?
??????
???????
 (1) 
This mathematical model, which can be applied to arbovirus transmission, shows that vectorial 
capacity (C) depends on many factors including: the abundance of vector mosquitoes per vertebrate  
host (m); the probability of a bite occurring (a); the probability of vector survival (p); the duration of the 
incubation period after which the vector can transmit the virus (n); the probability of vector survival 
after the incubation period is completed (1/−ln(p)); and the vector competence (b). Mosquito vector 
competence for arboviruses is an evaluation of the mosquito’s ability to become infected following an 
infectious blood meal and to subsequently transmit the virus. After the ingestion of an arbovirus by the 
female mosquito, it must overcome different barriers in order to be transmitted. The first is the midgut 
infection barrier (MIB) before the virus can invade the midgut epithelium where it undergoes replication 
in order to pass through the midgut escape barrier (MEB) and then disseminate to other tissues, finally 
reaching and infecting the salivary glands. The salivary gland infection barrier (SIB) and salivary gland 
escape barrier (SEB) are the final hurdles for arboviruses to overcome before they can be transmitted 
during a subsequent mosquito blood meal [20–22]. Mosquito vector competence for arboviruses has been 
shown to be determined by the genetic components of both the mosquito and arbovirus and their 
interactions, a phenomenon called genotype–genotype (GXG) interactions. Therefore, mosquito vector 
competence can vary among mosquito vector/arbovirus species and strains as well as between individual 
mosquitoes within one strain [20,23,24]. As arboviruses often exist as a collection of variable genomes 
within and among hosts, referred to as a mutant swarm [25], vector competence can also vary depending 
on the genome population of an arbovirus strain. Moreover, mosquito vector competence is dependent on 
environmental parameters such as temperature or symbiotic microbiota, as previously reviewed [24,26]. 
Thus, a considerable number of factors can influence competence, even in a same mosquito/arbovirus 
spp. combination. 
A change in any of the parameters of vectorial capacity for a specific pathogen can affect the spread 
of a disease. Therefore, control of Aedes mosquito vectors either by mosquito population reduction or 
replacement with refractory mosquitoes can play an important role in the fight against arboviral 
infectious diseases. The reduction of populations is aimed at decreasing the probability of vector survival (p) 
and the abundance of vector mosquitoes per vertebrate host (m) leading to a decrease in disease transmission. 
Proof-of-principle experiments and field trials of such strategies in Ae. aegypti have already been carried 
out using endosymbiotic Wolbachia bacteria [27,28] or genetically modified (GM) mosquitoes with the 
RIDL (“Release of Insects carrying a Dominant Lethal”) genetic system [29]. Replacing competent 
mosquito populations with refractory mosquitoes aims to reduce vector competence (b). Although vector 
competence is not the most important determinant of vectorial capacity, vectorial capacity fluctuates 
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directly with it as competence is a linear term in expressions of vectorial capacity. Therefore, reducing vector 
competence should lead to a decrease in the spread of a disease. Recently, significant advances in 
knowledge about the mechanisms of interactions between mosquitoes and arboviruses have been made, 
especially regarding the influence of mosquito antiviral responses on arbovirus propagation, genetic and 
phenotypic variation affecting these interactions, the impact of these interactions on mosquito fitness, 
and how environmental factors affect arbovirus transmission [23,26,30,31]. This opens the way for the 
development of novel disease control strategies by altering mosquito vector competence. 
In this review, we will focus on the development and application of biological approaches, either 
natural or engineered, to limit mosquito vector competence for arboviruses in Aedes spp. vectors. For 
overall relevance, some results obtained with other mosquito species, such as Culex or Anopheles, will 
also be reviewed. We discuss key aspects of mosquito antiviral pathways as targets, either for the 
selection of naturally resistant mosquito populations or for engineering transgenic mosquitoes resistant 
to viral infections. We will also consider the use of endosymbiotic bacteria such as Wolbachia, which in 
some cases have proven to be remarkably efficient in disrupting arbovirus transmission by mosquitoes. 
Further to this, we will discuss the use of naturally occurring insect-specific viruses that may interfere 
with arboviruses in mosquito vectors as well as paratransgenesis of endosymbionts to control mosquito 
vector competence. 
2. Natural Control of Arbovirus Transmission 
2.1. Mosquitoes Naturally Resistant to Arbovirus Transmission 
Although genetic engineering strategies to reduce Aedes mosquito populations [29] and the use of 
Wolbachia bacteria [32] have generated new opportunities in vector control, investigations into natural 
mosquito competence can serve to identify new targets for mosquito transgenic engineering or select 
resistant mosquitoes by breeding for population replacement strategies. As defined in the introduction, 
natural competence for pathogens can be due to a number of factors [24,26,30]. If environmental factors 
and viral properties are excluded, mosquito cellular factors such as receptors or proteins, extracellular 
factors and tissue-related properties (accessibility, cell types) can all potentially influence arbovirus 
midgut infection, replication and dissemination to the saliva. Many experimental studies have compared 
competence for arboviruses between regional strains of mosquito species or between species of mosquitoes 
and this section shall only address work where differences at genetic/molecular/physiological levels 
were observed that may inform vector control strategies. 
One of the first observations made was that a laboratory strain of Culex pipiens pipiens (Cx. pipiens pipiens), 
a natural vector of WNV, was refractory to this virus. Studies on the midgut of these mosquitoes revealed 
an induction of apoptosis in this tissue, which the authors linked to a failure to disseminate virus from 
the midgut [33]. 
Analysis of quantitative trait loci in Ae. aegypti has identified targets and given further insights into 
the genetics of DENV competence related to midgut infection and escape barriers [34–37]. However, 
while these loci can be pinpointed to individual chromosomes, the host genes remain to be identified. 
Advances in sequencing technologies over the last three to five years may now allow these data and 
mosquito strains to be analyzed further and candidate regions to be assessed in vivo. Nonetheless, some 
Insects 2015, 6 240 
 
progress on identifying the role of individual host molecules and their role in competence has been made. 
A putative DENV receptor present in mosquitoes that can be infected with dengue was identified [38], 
though more detailed descriptions and assays such as knock down studies are required to confirm this 
finding. More recently, Lambrechts and colleagues [39] suggested that polymorphisms in the Ae. aegypti 
Dicer2 (Dcr2, a key exogenous siRNAi pathway protein) are associated with resistance to DENV. While 
the exact mechanism of virus resistance due to Dcr2 polymorphisms is not known, these findings directly 
link mosquito innate immunity to resistance. Indeed, Dcr2 initiates the exogenous siRNA pathway by 
detecting and cleaving viral double-stranded RNA (induced by replication or potentially secondary 
structures) into 21 nucleotide virus-derived small interfering RNAs, a critical step in this antiviral response. 
The establishment of new techniques for genomics and for the analysis of differential gene 
expression, such as microarrays and more recently high-throughput sequencing, has allowed 
comparative studies between refractory and susceptible mosquitoes to be performed, and are novel 
opportunities for in-depth genetic studies. In the case of DENV2/Ae. aegypti interactions, comparative 
studies between susceptible D2S3 and refractory Moyo-D mosquitoes have shown that common factors 
up-regulated in response to infection include endocytosis, autophagy regulation and a number of other 
physiological processes; however, some genes linked to immunity were only up-regulated in the 
refractory strain suggesting a further role in competence [40]. Interestingly, genes linked to one of the 
insect’s immune signaling pathways, the JAK/STAT pathway, previously linked to the control of DENV 
in this mosquito [41] were also up-regulated in both strains in response to infection. This leads to the 
question of potential differences in the JAK/STAT pathway between these strains (for example in 
expression of antiviral effectors) and whether it is really a defining contributor to competence. To 
analyze this question, more detailed comparative studies on this pathway between strains would be 
required. The same authors also compared sub-strains of the Moyo Ae. aegypti mosquitoes that were 
either resistant (MOYO-R) or susceptible (MOYO-S) to DENV2 [42]. While again confirming the 
important role of the JAK/STAT pathway in both strains, a number of particularly intriguing responses 
or genes stand out. This includes a potential role for cell death in determining the refractory state, but 
also up-regulation of furin-like genes which could influence the maturation of viral structural proteins 
in the susceptible mosquito. A transcriptome study on Cx. pipiens quinquefasciatus mosquitoes with 
different competence for WNV recently identified genes involved in ovary development as being 
differentially transcribed [43]. Although no further investigations were carried out, comparisons can be 
complicated due to differences between technical approaches, arbovirus-vector combinations as well by 
the microbiota environment which can affect vector competence [26,30]. Moreover, mosquito genes 
identified in such analyses may have potentially unknown functions. Nevertheless, all these comparative 
studies show that arbovirus infections can induce a strong vector response, at least by a change in the 
transcriptome, and this response can be different between refractory and susceptible mosquitoes. 
Interestingly, it has recently been shown that DENV-refractory Ae. aegypti mosquito strains also present 
higher basal levels of numerous immunity-related gene transcripts compared to susceptible strains [44]. 
However, silencing antiviral defence pathways does not lead to a similar increase in viral load between 
refractory strains. This suggests that strain-specific restriction factors could operate independently of 
these pathways to limit viral replication in refractory strains. Conversely, silencing negative regulators 
of these defence pathways in susceptible strains does not always lead to a decrease in viral titers 
depending on the susceptible strain and the activated defence pathway. Therefore, basal levels of the 
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defence pathways’ transcriptome could tip the outcome of viral infection in mosquitoes. In addition, 
different degrees of the immune pathway activities, as well as strain-specific non-immune host factors 
and gene polymorphisms, contribute to control virus infection in refractory or susceptible strains [44]. 
Indeed, not all genes of interest may be up- or down-regulated and the identification of such candidates 
in the future may require other approaches, for example siRNA screens. 
All these studies link differences in the vector competence phenotype to molecular and genetic 
factors. Naturally resistant mosquitoes could thus be selected in the laboratory for replacement strategies. 
However, potentially many genome loci and gene products can affect mosquito competence for 
arboviruses. Thus, more studies will be required not only to understand the effect of genotypic variation 
and their interactions on controlling vector competence but also the influence of the environment on specific 
vector competence genotypes [24]. Moreover, mass rearing of naturally resistant populations from a few 
selected individuals to obtain refractory populations still needs to be carefully assessed. Indeed, the 
causes of variation resulting in different competence phenotypes between individual mosquitoes within 
one population is a challenge that has barely been explored [24]. A reduced genetic background in the 
founder population could also lead to an inbreeding depression after many generations [45]. With the 
exception of the selection of mosquitoes that are naturally resistant to arboviruses, these studies could 
provide important information for genetically engineering refractory mosquitoes. However, many of the 
potential targets identified in these screens will have to be assessed for their function and role in 
competence by knock down studies or other genetic approaches. This is becoming increasingly feasible 
as interest in vector biology is growing and more facilities for this work are being built or upgraded. 
Moreover, advances in engineering mosquitoes, as outlined elsewhere in this review, are hoped to be 
powerful enough in the coming years to implement the information gained from these interactions  
and host response studies in practice. Similar studies with alphaviruses and bunyaviruses remain to be 
carried out but the examples of DENV and WNV show that these are potentially very informative routes  
of investigation. 
2.2. Insect-Specific Endosymbionts to Decrease Mosquito Competence for Arboviruses 
2.2.1. Bacteria and Their Influence on Arbovirus Transmission: The Case of Wolbachia 
According to meta-analyses, an estimated 66% of arthropod species are thought to be infected with 
the intracellular α-proteobacterium Wolbachia [46,47]. Wolbachia spp. have been extensively studied 
due to their symbiotic relationship with the host, often leading to significant biological changes [48]. 
Critical to Wolbachia’s successful invasion of an arthropod species is their ability to manipulate host 
reproduction. In populations of mosquitoes and other arthropods, Wolbachia are spread and maintained 
through a phenomenon known as cytoplasmic incompatibility (CI) [48], which can be either 
unidirectional or bidirectional (Figure 1) [49]. Bidirectional CI results when males and females in a given 
population are infected with different strains of Wolbachia and viable offspring can only result from the 
mating of males and females infected with the same strain of Wolbachia. Unidirectional CI occurs when 
only one strain of Wolbachia is present in a population. In this situation, uninfected females only produce 
viable offspring with uninfected males, in contrast to infected females that are able to produce viable 
offspring with both infected and uninfected males; thus, giving these infected females a fitness advantage 
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over uninfected females. This phenomenon offers an intriguing possibility for the control of vector 
populations. As early as the 1960s, release experiments with mosquitoes infected with Wolbachia were 
carried out in order to eliminate wild Cx. pipiens populations [50]. In recent times, male Aedes polynesiensis
mosquitoes transinfected with Wolbachia were also released into wild populations in order to limit the 
population number through CI [51]. 
 
Figure 1. Wolbachia induced cytoplasmic incompatibility (CI) by infection. Wolbachia are 
spread and maintained in Aedes populations through a process known as CI which can be 
present in two distinct forms. Unidirectional CI involves infected females being able to 
successfully mate with both uninfected males in addition to those infected with the same or 
similar strains of Wolbachia. Bidirectional CI occurs in males and females infected with two 
different strains of Wolbachia which are unable to produce viable offspring. Both forms of 
CI result in females infected with Wolbachia having a fitness advantage. Circles indicate 
viable offspring and are color coded to demonstrate infection status. CI indicates where no 
viable offspring are produced. 
Despite the wide occurrence of Wolbachia within insect species, there are no accounts of natural 
infections occurring in the important arbovirus vector Ae. aegypti. However, Ae. albopictus is known to 
be infected with at least two strains of Wolbachia [52–54]. Other mosquitoes, such as Cx. quinquefasciatus
and An. gambiae, have been shown to be naturally infected with Wolbachia [55,56]. Before a recent study 
in Anopheles, it was assumed that like Ae. aegypti, An. gambiae were not naturally infected with 
Wolbachia [56]. This poses the question of whether we have simply not found wild populations of  
Ae. aegypti infected with Wolbachia. Indeed, if these populations do exist, they may have interesting 
characteristics with regards to arbovirus transmission that could be exploited. Apart from natural 
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Wolbachia infections, studies have indicated that Ae. aegypti and Ae. albopictus can be stably 
transinfected with Drosophila-derived strains of Wolbachia [27,57,58]. A virulent laboratory strain of 
Wolbachia originally isolated from Drosophila, called wMelPop, was found to be life shortening when 
transinfected into Aedes populations; although, it was stably maintained [57,59,60]. The life shortening 
phenotype of wMelPop was considered to be a viable mechanism for limiting transmission of 
arboviruses. Indeed, female mosquitoes can take several blood meals throughout adulthood, and 
shortening this period would potentially result in less arbovirus transmission. 
The full potential for Wolbachia as a tool to limit arbovirus transmission by mosquitoes became  
clear in 2008 when two independent studies showed that a Wolbachia infection in D. melanogaster  
led to a decrease in the replication and titers of several RNA viruses [61,62]. Subsequent studies have 
since indicated that Wolbachia transinfection can inhibit arbovirus transmission depending on the 
Wolbachia-mosquito-arbovirus combinations [55,61,63–68]. 
In Ae. albopictus infected with natural strains of Wolbachia, the presence of the endosymbiont  
does not lead to viral resistance in these mosquitoes and at best gives limited protection. For example,  
Bian et al. showed that the presence in Ae. albopictus of the native Wolbachia strains wAlbB and wAlbA 
did not significantly inhibit DENV replication [63]. However, further studies indicated that dissemination 
to the salivary glands was reduced, suggesting that this Wolbachia-host combination may limit DENV 
transmission [69]. Further to this, one study has indicated that wAlbB and wAlbA infected Ae. albopictus 
may, to some extent, be able to control the amount of CHIKV replication; however, not to a level that 
would allow the control of viral dissemination through the mosquito [70]. 
The mechanism(s) underlying the inhibitory phenotype are not well understood. Several key studies 
have indicated the importance of Wolbachia density in order to elicit an antiviral response or effect.  
For example, native Wolbachia are often present in high densities in Drosophila infections and as such 
offer natural viral protection [71]. Similarly, the transinfection of non-native Wolbachia often leads to a 
high density of the bacteria which has been linked to an antiviral effect [72]. A possible mechanism for 
the inability of native Ae. albopictus Wolbachia to efficiently control arbovirus infection in this species 
is that bacteria are present at very low densities [71,72]. This could suggest that a shared evolution 
history between Aedes mosquitoes/arboviruses and Wolbachia may have led to a reduced density of 
Wolbachia. Nonetheless, even in absence of a complete understanding of the inhibitory mechanisms, 
this strategy is being pursued. Artificial transinfections of Drosophila-derived Wolbachia strains into 
Aedes populations, most often Ae. aegypti can produce viable mosquitoes. Stable wMelPop transinfected 
Ae. aegypti were initially generated by firstly adapting wMelPop to an Ae. albopictus-derived cell line [73] 
prior to being transferred into an Ae. aegypti cell line for several passages before transinfection into  
Ae. aegypti mosquitoes [57]. Not only does this induce a life shortening phenotype and CI in this 
mosquito species, but several studies have also shown reduced proliferation of arboviruses, including 
DENV, CHIKV, YFV and WNV [66–68]. In addition, the introduction of another D. melanogaster 
derived strain, wMel, into Ae. aegypti does not limit the vector’s lifespan but does induce CI and is able 
to inhibit DENV [58,63], CHIKV and YFV [67] but interestingly not WNV [66]. Transinfection of 
wAlbB into Ae. aegypti is also able to inhibit DENV [63]. Similarly, Ae. albopictus has been transinfected 
with wMel again resulting in lower viral titers upon CHIKV infection [65]. 
Although the possibilities associated with Wolbachia are becoming increasingly recognized, the 
underlying mechanisms that block arbovirus infections are not as it is still unclear exactly how Wolbachia 
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control arbovirus replication or transmission, with the exception of the density-based hypothesis described 
above [26,32,74,75]. It is known that upon transinfection of Wolbachia, there is an up-regulation of some 
innate immune pathways in Ae. aegypti [76,77]. It has therefore been suggested that Wolbachia may 
offer antiviral protection by “priming” the immune system against incoming arboviral infections. In 
contrast, immune priming is not seen in naturally occurring Wolbachia infections, at least in Drosophila 
where viral protection is still seen [61,62,78,79]. Therefore, immune priming may not, or at least not 
always, be required for Wolbachia’s antiviral activity, even if it could enhance the bacteria’s viral 
interference [76]. Other hypotheses to explain the antiviral effect conferred by Wolbachia have been 
proposed, including tissue tropism and competition for host cell resources [26,32]. 
Nonetheless, the real test of Wolbachia-mediated strategies lies in release experiments. Several of 
these experiments have been carried out in order to assess the success of the introduction of Wolbachia 
into wild populations. Initial studies are encouraging and show that transinfected Ae. aegypti are able to 
effectively invade a small area/population of wild mosquitoes and produce a high infection rate [27,80]. 
Interestingly, a recent study in Australia indicated that Wolbachia infection was sustained a year 
following field release [81]. Upon experimental infection of mosquitoes collected from the transinfected 
population, DENV dissemination was shown to be reduced indicating that there is a persistent antiviral 
effect [81]. However, it is important to note that the release area did not have an ongoing DENV outbreak 
and any possible effect of a shared history between Wolbachia and DENV on antiviral protection could 
not be determined. The release of Wolbachia into wild populations requires extensive knowledge of the 
local and regional mosquito population, if fixation (i.e., stable introduction of Wolbachia into a 
previously naïve population) is to be successfully obtained [82,83]. Calculations of parameters such as 
the strength of CI, maternal inheritance rate and fitness cost of Wolbachia infection/transinfection must 
be performed [84]. Modelling experiments are then carried out to determine the minimum number of 
Wolbachia infected mosquitoes to be released [58,80,85–87]. These parameters are influenced by the 
presence of an existing Wolbachia infection in wild populations. Thus, local wild populations should be 
tested for the presence of Wolbachia prior to release; although, this may not be required for Ae. aegypti. 
Additionally, a recent study in Anopheles indicates that the natural gut flora of mosquitoes is able to 
inhibit the vertical transmission of Wolbachia [88]. Given that populations of mosquitoes in the wild are 
likely to vary in the composition of their gut flora, the spread of Wolbachia in these populations may be 
affected. Finally, it is also conceivable that the introduction of Wolbachia into wild populations may 
have an effect on the endogenous viruses present in these populations (see Section 2.2.2 on insect-specific 
viruses below) and it is unclear how this may impact on the ability to transmit arboviruses in the long term. 
2.2.2. Insect-Specific Viruses (ISVs) and Their Influence on Arbovirus Transmission 
In recent years, an increase in the systematic virus discovery in mosquitoes and other arthropods 
around the world has resulted in the documentation of insect-specific viruses (ISVs). These viruses are 
often characterized by their specificity to replicate in certain insects—for example mosquitoes—and 
inability to replicate in vertebrate (cells). The first viruses discovered in this group belong to the 
Flavivirus genus (family Flaviviridae), with cell fusing agent virus, Kamiti River virus and Culex 
flavivirus (CxFV) as well-known members of these insect-specific flaviviruses (ISFs) [89]. In recent 
times, mosquito-specific viruses belonging to other families/genera (Togaviridae, Bunyaviridae, 
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Densovirinae and Mesoniviridae), or as yet unclassified, have also been identified [90]. These data 
highlight the fact that a great number of mosquito strains in the wild are infected with mosquito-specific 
viruses. Although little is known about the transmission of these viruses, experimental data present for 
some of the ISVs as well as other supporting evidence, including the widespread nature of ISVs in wild 
mosquitoes, suggests that vertical transmission is the main factor for propagation [91–94]. Moreover, 
several well established mosquito cell cultures made from embryonic or larval mosquitoes have been 
reported to be persistently infected with ISVs [92,95,96]. Artificial ISV infections in naïve mosquitoes 
and cell lines often result in pathogenicity; however, the survivors show non-pathogenic persistent 
infection; although they still actively produce virus which can be transmitted to the offspring in a   
non-pathogenic matter [92,96–98]. Therefore, it can be expected that a wide number of mosquitoes are 
already persistently infected with ISVs at the time they encounter arboviral infections, resulting in 
mosquitoes infected with at least two different viruses (ISV and arbovirus) [99]. 
Little is known about the influence of these ISVs on arboviral infections in mosquitoes (Table 1).  
For several viruses (at least those belonging to Flaviviridae and Togaviridae), it has been reported that 
sequential infections (i.e., superinfection) by the same virus, or phylogenetically closely related viruses, 
in the same cells are inhibited, known as superinfection exclusion [97,100,101]; however, the 
mechanisms underlying this process are often not known. Some ISVs—for example, insect-specific 
flaviviruses—are phylogenetically classified in the same genus as several arboviruses that can be 
transmitted from mosquitoes to vertebrates. This is in contrast to others that do not have a counterpart 
that is able to be transmitted from invertebrates to vertebrates—for example, densoviruses (DNVs, small 
non-enveloped single stranded DNA viruses; Parvoviridae family, ambidensovirus genus). Therefore, it 
could be expected that superinfection exclusion happens regularly in nature and could possibly be used 
as a self-sustaining control measure. It is currently not known if ISVs and arboviruses share enough 
phylogenetic similarity for superinfection exclusion to occur; and even if theoretically possible, if this 
really happens in nature. However, ISVs could also trigger immune pathways in the female mosquito 
and thereby potentially prime the mosquito in a superinfection exclusion unspecific way, thus still 
limiting further infection by arboviruses not phylogenetically closely related to ISVs. 
Most current research has focused on dual infections of ISFs and mosquito-borne flaviviruses, more 
specifically CxFv and WNV either in Ae. albopictus-derived C6/36 cells or Culex mosquitoes [91,98]. 
Some reported an inhibitory effect, either by decreased viral titers or delayed disseminations, while 
others observed no effect. Recently, interference of a mosquito-borne flavivirus by two additional  
ISFs has been reported in vitro, resulting in lower titers of the mosquito-borne flavivirus [97,102].  
Moreover, one of them showed that the inhibitory effect of the insect-specific flavivirus, Palm Creek 
virus, was specific to sequential infection by mosquito-borne flaviviruses (WNV and Murray Valley 
encephalitis) and could not be observed during the sequential infection of a mosquito-borne  
alphavirus (Ross River virus) [97]; this would support the superinfection exclusion theory. On the other 
hand, the inhibitory effect or increased pathogenicity of the mosquito-borne flavivirus DENV in 
mosquito cells or mosquitoes persistently infected with the ambidensovirus DNVs [96,103], supports 
the ability of ISVs to interfere with arboviral infections even if they belong to different virus families 
within some combinations. 
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Table 1. Mosquito dual infections with insect-specific viruses (ISVs) and mosquito-borne viruses and their consequence on viral infection. 
Arbovirus ISV Experimental Host Experimental Outline Effect on ISV Effect on Arbovirus Reference 
DENV2  
(flavivirus) 
DNV  
(ambi-densovirus) 
Ae. albopictus  
(adults & larvae) 
DNV persistent infected 
mosquitoes, followed by 
DENV2 infection 
Titer increase 2–3 log 100× lower titer [103] 
WNV (flavivirus) 
MVEV (flavivirus),  
RRV (alphavirus) 
PCV (flavivirus) Ae. albopictus C6/36 
Arbovirus 6–7 dp PCV 
infection  
 
Lower titer for WNV and MVEV  
No effect on RRV 
[97] 
WNV  
(flavivirus) 
CxFv  
(flavivirus) 
Ae. albopictus C6/36 
Arbovirus 48 hp CxFV 
infection 
 
1 log lower titer at 108 hp infection. 
Other time points no effect 
[91] 
WNV  
(flavivirus) 
CxFv  
(flavivirus) 
Cx. quinquefasciatus 
CxFv persistent infected 
mosquitoes, followed by 
WNV infection 
 Delay in dissemination [91] 
DENV2  
(flavivirus) 
AalDNV  
(ambi-densovirus) 
Ae. albopictus C6/36 
Acute AalDNV infection, 
followed by DENV2 infection  
Persistent AalDNV infection, 
followed by DENV2 infection 
 
Increased CPE  
Decreased CPE 
[96] 
WNV  
(flavivirus) 
CxFv-Izabal  
(flavivirus) 
Ae. albopictus C6/36 WNV 48 hp CxFV infection   
Lower WNV titer from 4 dp 
infection (not significant) 
[98] 
WNV  
(flavivirus) 
CxFv-Izabal  
(flavivirus) 
Cx. quinquefasciatus 
Honduras/Sebring 
Co-infected by injection  
CxFv in salivary  
glands (Honduras 
Cx.quinquefasciatus) if  
co-infected with WNV only 
Increased WNV transmission [98] 
WNV (flavivirus)  
JEV (flavivirus)  
SLEV (flavivirus) 
NHUV  
(flavivirus) 
Ae. albopictus C6/36 
Arbovirus post or co-infected 
with NHUV  
 Lower titers [102] 
DENV, dengue virus (Flaviviridae, flavivirus); DNV, densovirus (Parvoviridae, ambidensovirus); WNV, West Nile virus (Flaviviridae, flavivirus); MVEV, Murray Valley 
encephalitis virus (Flaviviridae, flavivirus); RRV, Ross River virus (Togaviridae, alphavirus); PCV, Palm Creek virus (Flaviviridae, flavivirus); CxFv, Culex Flavivirus 
(Flaviviridae, flavivirus); AalDNV, Aedes albopictus densovirus (Parvoviridae, ambidensovirus); JEV, Japanese encephalitis virus (Flaviviridae, flavivirus); SLEV, Saint 
Louis encephalitis virus (Flaviviridae, flavivirus); NHUV, Nhumirim virus (Flaviviridae, flavivirus); hp, hours post; dp, days post; CPE, cytopathic effect. 
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Even if most experimental set ups to date have focused on the inhibitory effects on the arbovirus 
infection in the case of persistent ISV infections, representing the natural infection order, some 
experimental results suggest that the order and timing of the infections can affect the interaction and 
therefore the effect on the arbovirus infection outcome [96,98,102]. For example, after sequential 
infection with DENV, Ae. albopictus (Aal)DNV acutely infected C6/36 cells show increased cytopathic 
effects (CPE), while AalDNV persistently infected C6/36 cells show decreased CPE [96]. 
The large genetic diversity between ISVs, mosquito-borne viruses and mosquitoes suggest that the 
influence of ISVs on arboviral vector competence may indeed vary depending on the mosquito-ISV-
arbovirus combination [89,90]. This is supported by Kent et al. who reported an effect on WNV 
transmission in a colony of Cx. quinquefasciatus from Honduras if co-injected with an ISF from 
Guatemala (CxFV-Izabal) which was not found in a different Cx. quinquefasciatus colony (Sebring). 
Interestingly, in contrast to the inhibitory effects other studies show, they report an increase in WNV 
transmission [98]. This is in line with a reported ecological association between CxFV and WNV in field 
collected mosquitoes whereby Cx. pipiens positive for WNV were more likely to be positive for CxFV [99]. 
However, the increase in WNV transmission reported by Kent et al., in contrast to the other studies, 
could also be due to differences of virus administration (blood feeding or injection). On the other hand, 
Bolling et al. have reported an early suppression of WNV in CxFv persistently infected Cx. pipiens, 
resulting in delayed transmission of WNV [91]. 
These examples highlight the fact that although ISVs have a potential to be used to control arbovirus 
infections, more research is required to understand these interactions in detail before they could 
potentially be used as biological control measures. 
2.3. Entomopathogenic Fungi and Their Effect on Competence for Arboviruses 
To control adult mosquito vectors, a further alternative biological approach is the use of entomopathogenic 
fungi such as Metarhizium anisopliae (M. anisopliae) and Beauveria bassiana (B. bassiana). For a 
decade, these entomopathogenic fungi have been considered to be good candidates for decreasing 
pathogen transmission by mosquitoes mainly because of their ability to shorten the mosquitoes’  
life span or reduce the blood feeding success of female mosquitoes, both in Anopheles species  
malaria vectors [104–107] (further reviewed in [108]), and in arbovirus vectors such as Ae. aegypti and  
Ae. albopictus [109–111]. 
In addition, when Anopheles or Aedes adult mosquitoes treated with fungi take an infected blood 
meal, they are less competent for transmitting the pathogen to a suitable vertebrate host [104,112,113]. 
In Ae. aegypti, both B. bassiana and M. anisopliae reduce vector competence for DENV2 [112,113]. 
Interestingly, it has been shown that the Toll pathway, an insect immune signaling pathway, is activated 
in response to fungal infections in Ae. aegypti. This results in the transcriptional activation of several 
antimicrobial peptides (i.e., Cecropin, Defensin, Attacin, Diptericin and Serpin) and other immune  
genes [112,114]. Similarly, another immune pathway, the JAK/STAT pathway, responds to fungal 
infections in Ae. aegypti by up-regulating the transcription factor of JAK/STAT, Dome, and the dengue 
virus restriction factor, DVRF [112]. Studies have indicated that when Rel1 (Toll pathway controller), 
Dome or DVRF-1 (JAK/STAT pathway) are knocked down, Ae. aegypti adult females are more 
susceptible to fungal infections showing that Toll and JAK/STAT immune pathways exert an anti-fungal 
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immune defence in the mosquito [112,114]. As the Toll and JAK/STAT pathways have been identified as 
being antiviral against DENV infection in female Ae. aegypti mosquitoes [41,112,115], the fungi are suspected 
to inhibit DENV infection at least through the activation of the Toll and JAK/STAT pathways [112]. 
As entomopathogenic fungi decrease mosquito vector longevity, blood feeding success and viral 
infection in females (therefore reducing the number of mosquitoes that can bite and get infected), 
entomopathogenic fungi could be used as a biological tool to control arboviral transmission by mosquito 
vectors and therefore limit mosquito-borne diseases [108]. Both M. anisopliae and B. bassiana have 
been shown to decrease Aedes vectors’ survival and feeding success in semi-field conditions [110,111]. 
However, before the wider use and application of fungi in the field, the way different fungal strains 
interact with arboviruses in mosquitoes needs to be addressed to demonstrate their potential for reducing 
disease transmission. In addition, it should be determined whether an eventual selection of genetic 
resistance to fungi could have collateral consequences for mosquito competence [116]. Besides,  
long-lasting formulations and optimization of delivery methods will be required to achieve efficient 
vector control. To date, few trials have evaluated the use and delivery methods of fungi and their impact 
on mosquito vectors and disease transmission in the field. So far, results indicate that the delivery 
methods should exploit natural behavior of mosquitoes and be used as part of an integrated vector 
management strategy to be an efficient control tool [117–119]. Finally, if entomopathogenic fungi have 
a large host-range of target insects, then selected fungi, as well as delivery methods, should be evaluated 
with caution to minimise the risk of contaminating non-target insects further to assessing their safety 
regarding vertebrates and environment [108,120]. 
3. Engineered Control of Mosquito Arboviral Competence 
3.1. Engineering Mosquitoes with an Altered Arboviral Competence 
The recent availability of Anopheles, Aedes and Culex mosquito genomes [121–125] in addition to 
progress made in molecular biology, genomics and functional genomics together with the development 
of mosquito transgenic methodologies, have opened the way for the generation of novel vector control 
strategies using genetically engineered mosquitoes either to suppress or replace vector populations. 
While population suppression aims to reduce the number of disease-transmitting mosquitoes, population 
replacement aims to substitute wild type mosquitoes with ones that have impaired vector competence in 
order to block pathogen transmission [29,126–128]. Recent significant advances in our understanding 
of mosquito–arbovirus interactions and the mechanisms of how Aedes and Culex mosquito vectors 
mount a response to control arbovirus replication and infection [30,129–131] have provided new insights 
into the molecular bases of vector competence, which should help to engineer GM refractory mosquitoes 
that do not transmit arboviruses [31]. Here, we discuss potential targets and focus on mosquito genes 
and molecular responses that have been functionally characterized as influencing mosquito vector 
competence for arboviruses. 
3.1.1. Engineering Mosquitoes with Enhanced Antiviral Defences 
Among the antiviral defence pathways in mosquito vectors, the sequence specific RNA break-down 
mechanism RNA interference (RNAi) is a key player in limiting arbovirus replication [30,130,132,133]. 
Insects 2015, 6 249 
 
 
RNAi can be divided into several pathways depending on the small RNAs involved: small interfering 
(si)RNA, micro (mi)RNA and Piwi interacting (pi)RNAs. siRNAs or virus-derived siRNAs (viRNAs) 
are involved in the first antiviral RNAi pathway reported in mosquitoes: the exogenous siRNA pathway, 
which is an important pathway targeting arbovirus infections. The siRNA/viRNA pathway is induced 
by long double stranded (ds)RNA, which in the case of RNA viruses, could be viral replication 
intermediates, secondary structures in the viral RNA or virus genomes (in the case of dsRNA viruses). 
The dsRNA is recognized by the enzyme Dcr2 and cut into 21 nt long siRNAs/viRNAs, which in turn 
are taken up by the RNA induced silencing complex (RISC) harboring Argonaute 2 (Ago2) as the 
catalytic component. The siRNAs/viRNAs are then unwound and one strand is kept as a guide to  
find complementary (viral) sequences resulting in slicing and degradation of the specific (viral)  
RNA [130,133]. Transient knock down of the key proteins, Dcr2 or Ago2, in whole mosquitoes and 
derived cell lines, mainly from Aedes, results in an increase in replication of a variety of arboviruses 
from different families (DENV, CHIKV, SFV, ONNV, SINV) [134–139]. Nevertheless, little is known 
about the in vivo tissue-specificity of the siRNA/viRNA pathway, and it is still not clear in which 
mosquito tissues this pathway is endogenously expressed and active to protect the mosquito from 
arboviral infections. In Ae. aegypti, the exogenous siRNA pathway appears to be active and modulate 
vector competence for arboviruses at least in the midgut. Indeed, transgene-mediated silencing of Dcr2 
in the midgut of Ae. aegypti leads to significantly higher SINV titers in this tissue and dissemination 
rates of the virus throughout the rest of the mosquito [140]. Similarly, when a suppressor of the siRNA 
pathway, the Flock house virus B2 protein (FHV-B2), is overexpressed in the midgut of transgenic  
Ae. aegypti, SINV titers in the midgut and dissemination rates increase [141]. This further indicates that 
the SINV strain used in these two latter studies encounters a dose-dependent MEB in Ae. aegypti, and 
that the siRNA pathway controls this virus barrier in this instance. When the same transgenic mosquitoes 
are infected with DENV, the midgut infection titers increase, although to a lesser extent compared to 
SINV, indicating that the siRNA pathway also controls DENV replication in the midgut. However, in 
contrast to SINV infection, this does not lead to higher dissemination rates. It is possible, as mentioned 
by the authors of the study, that DENV failed to overcome a dose-dependent MEB because the viral 
titers in the midgut are still low and that the siRNA pathway is not the main factor controlling the  
dose-dependent MEB for this virus. However, the American DENV strain used in this study is known 
to be poorly efficient in overcoming the MEB in Ae. aegypti compared to other DENV strains [142–144]. 
Therefore, it is also possible that even if the siRNA pathway and others factors are capable of limiting 
DENV titers in the midgut cells, this particular virus strain may be confronted by a dose-independent 
MEB, such as an incompatibility between Ae. aegypti and this arbovirus strain, preventing the virus from 
exiting the midgut epithelial cells [141]. In contrast to Ae. aegypti, it has been recently shown in the malaria 
mosquito An. gambiae that the siRNA pathway does not influence ONNV midgut infection but only 
reduces virus replication in the systemic compartment after virus dissemination from the midgut [145]. 
Interestingly, the siRNA pathway is nevertheless active and functional in the midgut after ONNV 
infection, yielding viRNAs derived from the ONNV genome. This latter result suggests that this pathway 
could play a role in virus genome “antigen”-detection and immune system signaling rather than as a 
direct killing agent before viral dissemination from the midgut [145]. 
Recently, in addition to viRNAs, arbovirus-specific piRNAs have been detected in Ae. aegypti and  
Ae. albopictus mosquitoes and their derived cell lines for arboviruses belonging to different families 
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(Togaviridae: SINV, SFV and CHIKV; Flaviviridae: DENV; Bunyaviridae: RVFV, Schmallenberg virus 
and La Crosse virus), suggesting that the piRNA pathway also displays antiviral activity [138,146–150]. 
Little is known about the piRNA pathway in arthropods and even less in mosquitoes. Most of our 
understanding comes from the model organism D. melanogaster. Here, piRNAs are known to be 
important for genome stability by targeting transposons in the germline and surrounding cells. piRNA 
molecules harbor specific features due to their unique production pathways. The piRNA pathway can be 
divided into two parts. The first part results only in primary piRNAs (antisense with a bias for Uridine 
at position 1) and involves the Piwi and Aubergine proteins. This pathway is present in both somatic and 
germ line cells. The second part of the pathway involves an additional ping-pong amplification of  
the piRNAs, resulting in primary and secondary piRNAs (sense, with a bias for Adenine at position 10). 
This amplification loop involves the Ago3 protein and is, at least in the fruit fly, restricted to germline  
cells [133,151]. In contrast to D. melanogaster which has one PIWI, one Aubergine and one Ago3 protein, 
Ae. aegypti has seven PIWI, no Aubergine and one Ago3 protein [152]. Moreover, transcripts of Piwi 2–7 
and Ago3 can be found in somatic tissue of Ae. aegypti [138,146,148], suggesting some differences 
between the piRNA pathway in the fruit fly and Ae. aegypti. Combined knock down experiments of all 
Piwis and Ago3 in Ae. aegypti derived Aag2 cells followed by arbovirus (SFV) infection, suggested the 
involvement of these proteins in the production of viral specific piRNAs. Moreover, specific knock down 
of Piwi4 resulted in an increase of SFV infection [138]. Similarly, depleting Ago3 in An. gambiae 
mosquitoes increased ONNV titers [134], supporting an antiviral function of the piRNA pathway at least 
in mosquitoes. 
miRNAs are small RNA molecules shared by many organisms to post transcriptionally regulate 
transcripts. miRNAs mainly down-regulate transcript expression by translational inhibition or RNA 
degradation; although, positive regulation has also been reported. The miRNA pathway can be divided 
into canonical and non-canonical pathways and although it shares several similarities with the siRNA 
pathway, it encodes for specific miRNA pathway effector proteins. In contrast to the siRNA pathway 
which is solely cytoplasmic, miRNAs have both a nuclear and cytoplasmic phase. In the canonical 
pathway, transcripts from miRNA clusters are transcribed and folded back into partial dsRNA stem-loop 
structures called primary (pri-)miRNAs. Pri-miRNAs are cleaved into shorter precursor (pre-) miRNAs 
by Drosha, followed by export of the pre-miRNAs from the nucleus into the cytoplasm. It is here that 
Dcr1 cuts these into 21/22 nt miRNA/miRNA * duplexes which in turn are taken up by the miRISC 
harboring Ago1 as the catalytic compound. After unwinding the duplex, one strand is used as a guide to 
find (partial) complementary RNAs, resulting in their degradation or translational inhibition. Also, in 
contrast to siRNAs, miRNA/miRNA* duplexes are often not perfect dsRNA duplexes and can act on 
partially complementary target RNAs [133,153]. The non-canonical pathway shares many of the features 
with the canonical pathway; however, pre-miRNAs can also be produced independently from Drosha due 
to splicing and some miRNAs have been reported to be Ago2 dependent rather than Ago1 [154–157]. 
Evidence that the miRNA pathway in mammals acts antivirally is increasing. This can be either due to 
direct targeting of the viral RNA or indirect targeting by changing the environment in the cell to be less 
or more favorable for virus infection [158]. In mosquitoes, the transient knock down of the miRNA 
effector proteins Ago1 and Dcr1 did not result in up-regulation of replication for several mosquito-borne 
viruses (like alphaviruses), in contrast to the knock down of the exogenous siRNA effector proteins 
(Ago2 and Dcr2) [134,138,139]. However, changes in the miRNA profile in infected versus non-infected 
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mosquitoes or their derived cell lines have been reported for WNV (C. quinquefasciatus mosquitoes and 
Ae. albopictus C6/36 cells) [159,160], DENV (Ae. aegypti mosquitoes and C6/36 cells) [161,162] and 
CHIKV (Ae. albopictus mosquitoes) [163]. For most of the identified mosquito miRNAs, it is not yet 
known how important they are for arbovirus infection in mosquitoes and what their targets are. In 
addition, WNV and DENV have been reported to encode miRNAs in their viral genome, which can 
either target vector or viral transcripts [164,165]. 
Thus, genetically enhancing RNAi pathways in mosquitoes could reduce their competence for 
arboviruses and may provide a powerful tool for replacement strategies [128,130]. Several proteins 
involved in the RNAi response could also be used as potential targets for genetic control strategies; 
however, some are yet to be fully characterized to ensure their effect is limited to arbovirus infection 
and to minimize the risk of unwanted side effects. The exogenous siRNA pathway and its effector 
proteins (Dcr2 and Ago2) are potential targets that have broad antiviral activity and are currently the 
best studied. Proteins of the piRNA pathway also have the potential to be targets of genetic control 
strategies; however, more research is needed to investigate their involvement in the antiviral response 
against other arboviruses and their importance in mosquito genome stability. Targeting effector proteins 
of the miRNA pathway has a high chance of causing undesirable side effects in mosquitoes due to the 
importance of this pathway in gene regulation. Instead of targeting proteins of the RNAi pathway itself, 
some small RNA pathways can also be used directly. As a proof-of-principle, transgenic lines of  
Ae. aegypti which express a DENV2 sequence-derived dsRNA (following transcription of inverted-repeats), 
in the midgut or salivary glands, have been successfully used to artificially trigger the siRNA pathway 
against the DENV and exhibited reduced vector competence for DENV2 but not for other DENV 
serotypes [166–168]. 
In addition to the small RNA pathways, the major insect immune signaling pathways, i.e., Toll, IMD 
and JAK/STAT pathways, also control virus replication in infected mosquitoes, even if the precise 
mechanisms are still poorly understood [30,129]. These canonical innate immune pathways have  
been well described and the components and activity of these pathways against different microorganisms 
have been largely elucidated in D. melanogaster and extrapolated to vector mosquitoes as previously 
reviewed [169]. The major components of these pathways have also been identified in aedine and 
anopheline vector species [170,171]. As in the fruit fly, these pathways play a role in mosquito immune 
defences against parasites, fungi, bacteria and viruses [30,129,172,173]. The Toll pathway is activated in 
the presence of Gram positive bacteria, viruses and fungi as well as the rodent malaria parasite 
(Plasmodium berghei) while the IMD pathway is mainly activated by Gram negative bacteria, viruses and 
by the human malaria parasite (Plasmodium falciparum). The JAK/STAT signaling pathway has been 
implicated in antibacterial, antiviral, and antiplasmodial defence in mosquitoes. Stimulation of the Toll, 
IMD and JAK/STAT pathways leads to the activation and nuclear translocation of the transcription factors 
Rel1, Rel2 and STAT, respectively. This results in the expression of genes encoding antimicrobial peptides 
(AMPs) and other immune effector genes, leading to pathogen killing [30,129,172,173]. 
In contrast to the small RNA pathways, the contribution of each immune pathway can be different 
according to the arbovirus family and to arbovirus–mosquito interactions as described below. In response 
to DENV, both the Toll and JAK/STAT signaling pathways are activated in Ae. aegypti. Moreover, 
silencing of a negative regulator of the Toll pathway, Cactus, in Ae. aegypti mosquitoes results in a 
decrease in DENV infection of the midgut. Conversely, silencing of Myd88, a component of the Toll 
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pathway, resulted in an increase in DENV titers [115]. Similarly, silencing of the negative regulator of 
the JAK/STAT pathway, PIAS, leads to a reduction in DENV titers in Ae. aegypti mosquitoes, whereas 
silencing of positive regulators, Hop, Dome, or the JAK/STAT-regulated dengue virus restriction  
factor 1 (DVRF1) resulted in increased viral loads [41,112]. In the salivary glands of dengue-infected 
Ae. aegypti, both Toll and IMD were found to be up-regulated suggesting that these pathways might 
control virus infection in this tissue [174,175]. Moreover, a cecropin-like peptide, which has anti-DENV 
and anti-CHIKV activity, is induced in DENV infected Ae. aegypti salivary glands [174]. Thus, the Ae. 
aegypti mosquito vector seems to mount tissue-specific antiviral responses against DENV infection. The 
combination of the Toll, JAK/STAT and exogenous siRNA pathways appears to control DENV infection 
at least in the midgut; with Toll and IMD potentially acting as antiviral pathways in the salivary glands. 
Tissue-specific aspects of antiviral defences are further supported by differences in the overall 
transcriptome regulation upon DENV infection in different Ae. aegypti tissues, i.e., the midgut, salivary 
glands and carcass [115,174,175]. Interestingly, there are also differing degrees of immune pathway 
contribution to control virus infection in refractory or susceptible strains of Ae. aegypti [44]. For 
example, the IMD pathway controls DENV infection in the midgut of Ae. aegypti resistant strains only, 
as shown by increased viral loads in IMD depleted mosquitoes. However, the situation is less clear in 
susceptible strains. Up-regulating the IMD pathway by silencing Caspar, a negative regulator of the IMD 
pathway, has no effect on midgut DENV infection. However, as IMD has not been directly knocked 
down in these susceptible strains, it is difficult to tell whether this pathway is already operating at maximum 
capacity without any endogenous inhibition by Caspar, or whether it is not active or not protective against 
DENV midgut infection in susceptible strains [44,115]. In addition, DENV-refractory Ae. aegypti 
mosquito strains present higher basal levels of numerous immunity-related gene transcripts compared to 
susceptible strains suggesting that variation in the transcriptome influences vector competence [44]. 
Exposure to gut microbiota, which has been shown to stimulate basal antiviral immunity and decrease 
Ae. aegypti vector competence for arboviruses, may explain these transcriptome variations to some 
extent but inherent differences in gene regulation may also underlie these observations [115]. 
In the case of Aedes mosquitoes infected by alphaviruses, an antiviral function of the canonical innate 
immune pathways has not been yet demonstrated. However, little evidence supports the hypothesis that 
they could be involved in Aedes responses against this virus family as well. Upon SINV infection of 
female Ae. aegypti mosquitoes, Dif, a Toll pathway-activated transcription factor is increased after  
one day post-infection in the midgut and malpighian tubules, although it returns to basal level by day 4  
post-infection. The authors suggested that this is linked to suppression of Toll pathway activation by 
SINV once replication has taken place [176]. Additionally, infection of mosquito cells with SINV resulted 
in the translocation of the Rel2 protein into the nuclear fraction of Ae. albopictus C6/36 cells indicating 
that infection with this virus may also result in IMD pathway activation [177]. Fragkoudis et al. and 
McFarlane et al. used reporter assays to investigate the interaction of the innate immune pathways in 
mosquito derived cell lines with SFV and CHIKV, respectively. In Ae. albopictus derived U4.4 cells, SFV 
can repress activation of the IMD, JAK/STAT and Toll pathways [178]. Similar results were observed 
in Ae. aegypti derived Aag2 cells using CHIKV replicon constructs where pathway induction was also 
inhibited through host cell shut-off mechanisms [139]. In addition, prior stimulation of the JAK/STAT 
and/or IMD pathway (the assay cannot distinguish between them) resulted in a decrease in SFV replication, 
though CHIKV seemed to be unaffected by the activation of the three main immune pathways [139,178]. 
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The contribution of each of the innate immune pathways in different mosquito body compartments during 
the stages of an alphavirus infection is better characterized in An. gambiae infected by ONNV. Unlike 
Aedes infected with flaviviruses, the exogenous siRNA is not the first line of natural antiviral defence in 
the midgut, but interplay between the IMD and JAK/STAT pathways, as well as extracellular immune 
factors, limit virus infection [145]. In contrast, the Toll and exogenous siRNA pathways control viral 
load once the virus has escaped from the midgut into the systemic compartment [145]. 
Thus, mosquitoes have naturally developed complex antiviral defence strategies with an arsenal of 
pathways (certainly the RNAi and major immune pathways discussed above) to fight arboviral infections. 
Moreover, even if more functional studies are needed to highlight differences in vector responses to 
infection by different arboviral families, these tissue-specific mosquito antiviral strategies appear to be 
influenced by arbovirus-mosquito strain combinations and thus, by genome evolution of both the 
mosquito vector and the virus. This can partly explain natural variations in mosquito vector competence 
for arboviruses which is affected by the specific combination of mosquito and virus genotypes, as well 
as by environmental factors, such as the naturally present gut microbiota [26,30]. Therefore, copying 
natural antiviral strategies and engineering mosquitoes with enhanced antiviral defences is a promising 
approach to decrease mosquito vector competence for arboviruses and to control their transmission. 
3.1.2. Limits and Technical Challenges to Engineer Mosquitoes with Enhanced Antiviral Defences 
In order to design efficient transgenic mosquitoes with enhanced specific antiviral defences, more 
experimental research is needed to better understand the contribution of tissue-specific antiviral 
strategies in the mosquito, defence pathway crosstalk, as well as communication between different 
mosquito tissues during a viral infection which leads to an integrated antiviral response. For this to be 
achieved, and to test the influence of different potential targets for each mosquito–virus pair, mosquito 
genetic tools are essential. Ae. aegypti transgenic lines modified to overexpress or to repress the Toll and 
IMD immune pathways, as well as AMPs (e.g., cecropin and defensin), have already been engineered to 
decipher the mosquito immune response during mosquito–pathogen interactions; although, these have not 
yet been tested against arboviruses [179–184]. In these transgenic mosquitoes, the immune modifications 
are driven by the Vitellogenin gene (Vg) promoter which is responsive to blood feeding and mainly drives 
expression in the fat body between 12 and 48 h post blood meal [115,181,183,185]. Thus, it may not be 
the best promoter to assess an infection in the fat body which may occur later during DENV infections. 
However, these lines could be tested against CHIKV which disseminates from the gut to peripheral 
organs, such as salivary glands, more rapidly than DENV [186,187]. Moreover, the fat body is a tissue 
with important immune functions [172], and even if the virus is not yet present or does not disseminate 
to the fat body, this tissue could participate in the integrated antiviral immune response following 
communications between tissues triggered by viral midgut infection. 
It is necessary to identify mosquito regulatory sequences to drive expression of transgenes in a  
tissue-specific manner; not only to decipher the molecular basis of mosquito antiviral defences at the 
tissue-level, but also because in the context of population replacement, a transgene should be limited to 
a specific time and tissue to achieve the maximum effect on the pathogen with the least fitness costs to 
the vector [31,188,189]. The choice and design of the promoters should not only take into consideration 
the tissues with immune properties but also the mechanisms by which arboviruses disseminate in the 
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mosquito, their tissue/cell-specific tropism, and persistence in tissues. From the midgut to the salivary 
glands, various mosquito organs and cells have been shown to be infected with arboviruses such as the 
trachea, the fat body, the muscles, the cardia and the head [186,190–194]. Interestingly, the hemocytes 
(the immune cells of insects) can be infected by arboviruses in different species of Aedes, in Cx. pipiens 
as well as in An. gambiae [145,195]. Since hemocytes play a role in mosquito immunity [172], it would 
be interesting to determine if these cells are a site of viral amplification and whether they act as viral 
transporters in or through the hemolymph and/or if they play a defensive role against viruses. Like the 
Vg regulatory region driving gene transcription in the fat body, different promoter expression patterns 
have already been characterized and used to drive tissue-specific transgene expression in adult  
Ae. aegypti transgenic mosquitoes. In the midgut, the aedine Carboxypeptidase A promoter drives 
transgene expression in the female midgut after blood feeding [140,166,196–198]. The aedine 30K gene 
family promoter directs specific expression in the salivary glands of transgenic Ae. aegypti females [168]. 
The Maltase-like I gene promoter also drives gene expression in salivary glands, but in both sexes, and 
the Apyrase gene regulatory sequence controls expression in the female salivary glands but also in other 
tissues [199]. In flight muscles, transgene expression can be directed by the Actin-4 promoter [200]. 
Lastly, the regulatory sequence of Polyubiquitin (PUb) gene drives expression in all stages of 
development and most tissues. Nevertheless, this promoter drives strong expression in the midgut and 
to a lesser extent in secondary tissues like the salivary glands [141,201]. It would be useful to identify 
and characterize more regulatory sequences particularly for the hemocytes or the trachea, for which no 
regulatory regions have been identified so far. To find candidate promoters for hemocytes, the 
transcriptomic analysis by Choi et al. which compares gene expression between hemocytes and carcasses 
in Ae. aegypti could be used to select some interesting genes up-regulated in hemocytes [202]. Moreover, 
this study shows that some hemocyte-specific transcripts in Ae. aegypti are conserved in An. gambiae 
and D. melanogaster, allowing for the selection of aedine promoters that have already been shown to be 
functional in D. melanogaster hemocytes. For the trachea, different gene promoters have been 
characterized in D. melanogaster, such as breathless [203], which could be further tested in mosquitoes. 
The Gal4-UAS system, widely used in Drosophila, has proven to be one of the most powerful techniques 
for addressing gene function in vivo and for the characterization of regulatory regions [204,205]. A key 
advantage of the system is the separation of the two components in transgenic parental lines, the Gal4 
driver line and the UAS responder line, which ensure that the transgene is silent until Gal4 is introduced 
through a genetic cross (Figure 2). The Gal4-UAS system is functional in Ae. aegypti and two Gal4 lines, 
CpA-Gal4 and Vg-Gal4, as well as a UAS-EGFP line have been already established [185,198]. The 
development of this system in aedine mosquitoes, along with advances in transgenic technologies to edit 
the mosquito genome, such as the site-specific insertion system PhiC31 [206–208] or gene knock outs 
with TALE nucleases [209,210], should facilitate the generation of genetic tools to decipher mosquito 
antiviral strategies and to engineer refractory mosquitoes. Moreover, the CRISPR/Cas9 editing system, 
which promises to transform genome engineering in different species including insects [211,212], has 
been recently adapted in Ae. aegypti and allows the generation of mutations as well as homologous 
recombination [213]. 
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Figure 2. Schematic representation of the Gal4-UAS system. In a first line, the driver line, 
the yeast transcriptional activation factor Gal4 is under the control of a promoter directing 
the expression in the tissues/cells of interest. In the other line, the responder line, the 
transgene of interest is expressed under the control of the upstream activation sequence 
(UAS). As transcription of the transgene requires the presence of Gal4, the transgene is silent 
in the parental responder line. When the driver line and the responder lines are crossed, the 
transgene is then expressed according to the Gal4 pattern. 
Importantly, mosquito responses to infection can vary depending on the specific arboviruses involved 
as highlighted above, and more generally among other pathogens too. Thus, decreasing vector 
competence for one arbovirus could increase vector competence for another pathogen. Besides, a 
mosquito vector for a given arbovirus could bite people infected with other arboviruses or pathogens in 
a same geographic area. To avoid shifts in vector competence which could consequently alter their 
capacity for other pathogens and lead to an increase in non-target diseases, every transgenic mosquito 
with enhanced antiviral defences for a given arbovirus should be tested for its ability to be infected and 
transmit other pathogens before any release program is implemented. Immune evasion of arboviruses 
and their potential evolution should also be considered when designing transgenic mosquitoes with 
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modified defence properties. Indeed, arboviruses may develop counter defences to evade or suppress 
host defences and persist in the defending mosquito, therefore increasing mosquito competence and virus 
transmission. The mechanisms are not yet well characterized but may involve, for instance, 
transcriptional down-regulation of immune genes, decreases in RNAi pathway function as a result of 
viral suppressors of RNAi, genome nucleic acid sequence- or genome secondary structure-mediated 
resistance to RNAi [129]. Indeed, almost all arboviruses are RNA viruses, and as such they rapidly 
replicate with high mutation rates promoting the emergence of new variants. This can therefore lead to 
an increased fitness in their mosquito hosts as reported for DENV or CHIKV [142,214–217]. 
3.1.3. Other Strategies for Engineering Mosquitoes with an Impaired Arboviral Competence 
As discussed above, enhancing defence pathways to decrease mosquito competence for a given 
arbovirus could not be functional for every example. Perhaps, a more viable strategy rather than 
constitutively activating a defence pathway would be to identify a broadly acting antiviral molecule 
which could either be overexpressed or knocked down. There have been a number of these types of 
screens performed in recent years with the aim of finding broad acting antiviral or pro-viral mosquito 
proteins which have the potential to influence mosquito competence for arboviruses. For example, a 
comparative transcriptomic analysis of Ae. aegypti mosquitoes infected with the flaviviruses DENV, 
WNV and YFV, identified a number of proteins, including the histone core H3 protein, which are 
activated or down-regulated in response to infection, suggesting broad pro- or anti-viral roles for these 
proteins [218]. However, the antiviral role of these proteins in mosquitoes would have to be functionally 
characterized for these viruses as well as for other arbovirus families before targeting could be 
considered. Interestingly, this screen identified a reduction in chitin-binding related transcripts upon 
infection of Ae. aegypti with all three flaviviruses and these proteins were also identified in a screen of 
mosquitoes infected with SINV [176,218]. Similarly, candidate genes responding to DENV infection or 
those which where differently regulated between refractory and susceptible Ae. aegypti strains in the 
midgut or salivary glands, have been identified again through transcriptomic analyses [44,115,174,175]. 
For instance, the vacuolar ATPase complex, which regulates endomsomal pH, has recently been identified 
in one of these screens and was shown to be required for DENV replication in Ae. aegypti [44]. In addition, 
a large RNAi screen in D. melanogaster identified hits that have been shown to mediate antiviral activity 
against a number of virus families. For example, components of the Tip60 complex, including RUVBL1, 
RUVBL2 and TIP60, and a nuclear export factor, XPO1, were not only shown to be antiviral against a 
whole range of RNA viruses in Drosophila S2 cells but also in Ae. aegypti Aag2 cells [219]. Interestingly 
the proteins identified in this screen have been shown to be antiviral in vector mosquito cell lines as well 
as in mammalian cell lines which suggests that they have essential roles in the virus life cycle and could 
prove to be an attractive target for antiviral control in vectors [219]. Additionally, in Cx. pipiens 
quinquefasciatus mosquitoes, in addition to Cx. quinquefasciatus and Ae. albopictus cell lines, a secreted 
antiviral protein, Vago, was shown to be induced in a Dcr2-, TRAF- and Rel2-dependent manner in 
response to WNV and DENV infection. After secretion, Vago activated antiviral gene expression via 
the JAK/STAT pathway, thus restricting WNV replication [220,221]. Targeting host proteins with  
pro-viral functions such as virus receptors or proteins hijacked by the virus to replicate and disseminate 
is also an alternative strategy to modulate mosquito competence for arboviruses. However, few proteins 
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and mechanisms have been identified and even less characterized in mosquitoes. Nup98, a protein that 
promotes the recruitment of the elongating form of RNA pol II at antiviral gene loci and other proteins 
involved in the transcriptional pausing process, thus allowing for rapid activation of antiviral genes upon 
virus infection, is important in controlling virus infections in Drosophila S2 cells and Ae. aegypti Aag2 
cells [222,223]. A better understanding of the cells and tissues infected by arboviruses should also 
facilitate functional characterization of other host cell processes and host factors that are involved in the 
autonomous cell-control of virus replication, such as autophagy and apoptosis of infected cells, as it has 
not yet been determined if these cellular processes have an antiviral function or facilitate viral 
dissemination in mosquitoes [30,130]. 
Another possible genetic control approach to decrease transmission could be “death-on-infection” as 
reviewed previously [188]. This involves transgenic mosquitoes carrying a lethal effector activated by 
pathogens leading only to the death of infected mosquitoes. This original approach acts on vector 
longevity and not on vector competence and is therefore not discussed here. Nevertheless, Carter et al. 
recently developed an elegant strategy by coupling the targeted ribozyme capabilities of the antiviral 
group I intron with the generation of an apoptosis-inducing transcript. This leads to virus trans-splicing 
with the pro-apoptosis transcript resulting in virus genome cleavage and cell death upon infection and 
has been successfully used to suppress DENV infection in Ae. albopictus C6/36 cells [224]. Based on 
natural infection rates of midgut cells and the regenerative capabilities of midgut epithelia, the authors 
expect that the loss of cells will not have a significant impact on the survival of the transgenic  
mosquitoes but will only limit vector competence. Moreover, this system targets all DENV serotypes.  
Therefore, this “cell death-on-infection” is a promising tool to decrease mosquito competence even if it 
has not yet been demonstrated to work in vivo. 
A different death-on-infection-derived strategy would be to increase mosquito vector competence so 
as to render them hypersensitive to arboviral infection leading to mosquito death. In contrast to arbovirus 
infections in vertebrates, it has been traditionally considered that arboviruses are benign to their 
mosquito hosts, leading to “persistent” infections. However, a recent meta-analysis showed that 
arbovirus infections do reduce mosquito survival [225]. Different hypotheses, mainly arising from 
studies with the malaria mosquito, may explain the loss of mosquito fitness associated with pathogen 
infection cost, such as tissue- and cell-pathogenicity, resources competition, and the costs of the anti-pathogen 
defences [226]. As reviewed above, mosquitoes do naturally fight an arboviral infection. Thus, the 
“persistence” of arbovirus infections in mosquito vectors is only a reflection of mosquito competence, 
i.e., the mosquito’s ability to become infected by a virus which can survive long enough to reach the 
salivary glands and be transmitted. This is partly fine-tuned by a balance between the mosquito antiviral 
defences to control virus replication and survive the infection versus the virulence of the virus to be 
transmitted without killing the vector [31]. Therefore, it might be possible to imbalance these interplays 
by decreasing mosquito antiviral pathways (i.e., increasing mosquito vector competence) in favor of the 
virus, resulting in an increase in virus-induced mortality. In Ae. aegypti, a few studies have assessed the 
survival of mosquitoes which present decreased antiviral defences and increased infection titers through 
silencing of the exogenous siRNA pathway, and results are contrasting. Two studies have shown a 
decrease in survival rates of mosquitoes infected by a recombinant strain of SINV that expresses FHV-B2, a 
suppressor of the siRNA pathway [227,228]. In contrast, some other studies reported no evident decrease in 
survival in mosquitoes infected with DENV or SINV [135,136,140,141]. In the latter case, it has been 
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suggested that the siRNA pathway was not silenced/inhibited enough to increase virus titers above a certain 
threshold to induce mortality. Therefore, with the aim of developing immuno-deficient mosquitoes to 
decrease transmission of arboviruses, further studies would be required to better understand the 
mechanisms involved in the fitness cost of arbovirus infection on the mosquito. 
3.1.4. Future Challenges for Mosquito Population Replacement 
Whatever the strategy, a prerequisite for release programs of GM mosquitoes is the stability of the 
introduced transgene within transgenic strains over many generations [31]. First, transgene expression 
can vary among and within transgenic insect strains due to position effects, i.e., the influence of 
neighbouring enhancer or repressor elements on the inserted transgene [229,230]. The use of insulators 
can avoid these effects and enable stable expression of transgenes [191]. Exogenous insulators from 
Drosophila have already been used successfully to stabilize the expression of transgenes in Anopheles 
mosquitoes [231]. Insulators have also been identified and characterized in Ae. aegypti [232] although 
they have not been demonstrated to be functional in transgenic mosquitoes. Generating GM mosquitoes 
through site-directed integration, such as the PhiC31 site-specific transformation system, in well 
characterized docking sites could also reduce position effects [233,234]. Furthermore, fitness losses 
caused by a transgene, or insertion/expression of an exogenous transgene in an organism may lead to 
silencing of transgene expression. For example, transgenic lines of Ae. aegypti which were resistant to 
DENV2 in the midgut, lost their resistance phenotype after many rearing generations due to a loss of 
transgene expression [166,235]. Interestingly, the same authors recently showed that outcrossing  
a newly established line with the same transgene into genetically-diverse strains over many generations 
can reduce the fitness cost associated with the transgene [167]. This further supports the inbreeding 
depression phenomenon previously described in mosquitoes [45]. 
However, the main issue with genetically manipulating the mosquito defence system is the fitness 
costs this may have on the mosquito vector [31,236–238] even if, in the context of infection,  
the transgene-mediated resistance can confer a fitness advantage [237,239]. One would have to ensure 
that the fitness of transgenic mosquitoes is not affected by the effect of the transgene or the insertion  
per se as during release experiments such genetically modified vectors would quickly be outcompeted 
by wild type vectors and any antiviral effect would be lost. Using site-specific transformation  
systems and fitness-tested docking lines could overcome fitness loads associated with the transgene 
insertion site [240,241]. On the other hand, only directing transient expression of the transgene in a 
tissue- and stage-specific manner, as discussed above (Section 3.1.2), or inducing it only upon arbovirus 
infection using an arbovirus-induced promoter, should limit the negative effects of the antipathogen 
transgene [31,188,189]. Moreover, associating the gene which results in a refractory organism with a 
strong gene drive mechanism to spread the transgene into natural mosquito populations should allow 
mosquitoes with modified antiviral properties to be engineered that could represent viable tools for 
disease control [29,31,127,128,188,242,243]. A recent model-based study has evaluated the efficacy of 
several genetic strategies to control disease vectors. This work has shown that population replacement 
with GM refractory mosquitoes is easier to maintain and should lead to a greater long-term reduction in 
competent vectors compared to population reduction approaches, therefore encouraging antipathogen 
strategies [244]. 
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Finally, ethical and regulatory considerations impose that each GM product must proceed through a 
risk assessment process to evaluate the benefits and risks which may require a case-by-case approach. 
Before implementing the release of GM mosquitoes with altered vector competence, the way in which 
these mosquitoes could be deployed effectively, efficiently and safely in the field remains to be determined 
and will require semi-field test experiments. Public acceptance will also be key to implementing genetic 
control of mosquito competence to decrease disease transmission [14,29,127,245]. 
3.2. Using Paratransgenesis Approaches to Decrease Vector Competence for Arboviruses 
Paratransgenesis is an approach where endosymbionts commonly found in insect disease vectors are 
genetically modified to express anti-pathogen effectors so as to reduce insect vector competence. The main 
characteristics of paratransgenesis are the relative simplicity with which symbionts can be transformed 
with reduced fitness costs compared to insect transgenesis, the feasibility of the transformed endosymbiont 
to spread across an insect population, and the insect-specificity [246]. 
Several characteristics are important for such endosymbionts to be used as successful expression 
vectors to control mosquito competence for arboviruses, specifically regarding practicality and safety 
regulations. Firstly, it should be mosquito-specific or at least insect-specific and be unable to infect 
vertebrates. Secondly, it should have the capability to be stably modified. It would also be useful  
if it was not pathogenic by itself in the mosquito and had little impact on the host. Its ability to be 
vertically transmitted could be useful as this would increase the sustainability of the antiviral effect in 
mosquito populations and reduce the need for additional release experiments. On the other hand,  
vertical transmission could be a disadvantage due to the limitation of controlling the spread of the 
modified symbiont. 
Although several endosymbionts, such as bacteria or viruses, have these characteristics, the only ones 
currently being exploited for commercial use in mosquitoes transmitting arboviruses are ISVs, and more 
particularly mosquito-specific DNVs. The Ae. aegypti (Aae) DNV was the first reported densovirus 
isolated from mosquitoes in 1972 [247]. When Ae. aegypti larvae are transduced with a recombinant 
AaeDNV carrying a GFP reporter gene, the fluorescent protein is expressed in different mosquito tissues 
(e.g., gut, malpighian tubules and anal papillae) during the larval and pupal stages [248]. Studies have also 
been successfully performed in Ae. albopictus derived C6/36 cells and larvae using an AaeDNV derived 
vector, to express either an insect-specific toxin [249] or a short hairpin construct for gene specific 
silencing [250]. The use of DNVs is not limited to Aedes species and has also been shown to be efficient 
in An. gambiae. The protein of interest is preferentially expressed in adult mosquitoes in a wide range 
of tissues, including the fat body and ovaries; however, no expression was detected in the key tissues 
during arboviral infections, i.e., the midgut and salivary glands [251–253]. A disadvantage of DNVs is 
their small genome, which may not tolerate long additional sequences; therefore, studies so far have used 
a DNV-based expression system that is dependent on helper plasmids and co-infections with wild type 
DNV to induce the spread of the recombinant DNV construct [249–251]. Arboviruses from different 
virus families (Togaviridae, Bunyaviridae and Flaviviridae) have been shown to successfully express 
foreign genes; however, these experiments with their ISV counterparts have yet to be performed. It can 
be expected that in the future, work performed with DNVs will be broadened to ISVs belonging to other 
virus families, using the knowledge retrieved from years of arbovirus research. 
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In addition to ISVs, mosquito bacterial symbionts could also be transformed to express molecules 
which interfere with arboviral transmission. This is already in development for different insect disease 
vectors, such as malaria mosquitoes, by using bacteria of the Asaia genus [246,254]. Since Asaia have 
been reported to be associated with Ae. aegypti and Ae. albopictus, using these bacteria to express 
antiviral molecules might be another paratransgenic strategy to modify mosquito vector competence for 
arboviruses and decrease mosquito-borne viral disease transmission [254]. 
In the context of controlling mosquito arboviral vector competence, using genetically modified 
bacteria or ISVs, efficient arbovirus-specific antiviral molecules still need to be characterized. Moreover, 
mosquito microbial ecology and the role of this microbiota need further investigations in order to select 
transformable endosymbionts for each vector. Furthermore, how engineered symbionts can be spread in 
the field and replace non-transformed symbionts in natural mosquito populations needs to be assessed 
in both laboratory and field experiments. Additionally, a drive system, such as co-infection with the 
engineered symbiont and Wolbachia, could increase the frequency in mosquito populations of the 
transformed symbiont, and potentiate the effectiveness of replacement to achieve successful 
paratransgenic control of mosquito competence for pathogens [246,255]. 
4. Conclusions 
Here, we summarized the control strategies that are being developed to limit mosquito vector 
competence (Figure 3). The identification of antiviral pathways in mosquitoes has opened new 
intervention possibilities; but other factors, such as receptors or any pro-viral protein, are also of interest 
as targets for modification. Clearly, more information about natural resistance of vectors to arboviruses 
and the underlying genetic factors is also required. This can inform strategies based on the selection of 
traits or genetic modification strategies and a number of difficulties are likely to arise. It is not known at 
present, and it is also difficult to predict, how such genetically modified mosquitoes may fare against 
their wild type counterparts but this needs to be assessed for each population individually, in particular 
with regards to the key arboviruses in the study or release area. Paratransgenesis approaches combine 
several ideas but this field is still novel and the ideal targets still need to be identified. Nonetheless, the 
use of Wolbachia and RIDL technology suggests that vector-based control strategies and our increasing 
understanding of vector biology are ready to move the field further and improve current measures in 
vector control. Whatever the strategy to reduce vector competence of Aedes spp. vectors, a greater 
understanding of the interactions between arbovirus, mosquito and endosymbionts (such as gut bacteria and 
ISVs) is needed to avoid any negative impacts, such as the increase in transmission of a non-targeted 
arbovirus. For the same reason, every strategy will have to be assessed for mosquito vector competence 
to different mosquito-borne pathogens. In addition, as different mosquito species in a same geographic 
area can be responsible for arbovirus transmissions, it may be necessary to target more than one mosquito 
species to efficiently decrease disease transmission. Last but not least, engagement with the public is a 
critical point in taking such approaches forward and the experience and processes currently being built 
up will help future efforts. 
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Figure 3. Summary of the currently proposed natural and engineered strategies to decrease 
mosquito competence for arboviruses. 
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